(Total Views: 562)
Posted On: 10/19/2022 5:52:26 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Love this new move adding the new director to replace Dr K. On the board. Every move since NP left is an upgrade. Dr K can now focus on the day to day operation of getting this drug approved while the new board member brings a vast and deep background as an ex CEO of pharmas that have been acquired as well as significant board experience. This is a no brainer ..
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)